Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fowler, C. E.
Right arrow Articles by Oakes, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fowler, C. E.
Right arrow Articles by Oakes, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 40, 877-879, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy


ORIGINAL ARTICLES

MICs of rifampicin and chloramphenicol for mucoid Pseudomonas aeruginosa strains are lower when human lactoferrin is present

CE Fowler, JS Soothill and L Oakes
Department of Pathological Sciences, University of Manchester, Manchester Royal Infirmary, UK.

MlCs of rifampicin and chloramphenicol for mucoid strains of Pseudomonas aeruginosa were lower in the presence of human lactoferrin (0.9 mg/mL, the concentration found in cystic fibrosis sputum) than in its absence. MICs for some strains were lowered to clinically achievable levels of the antibiotics, which is compatible with impressions of greater clinical efficacy in pseudomonas infections than would be predicted by standard sensitivity tests. The routine addition of lactoferrin to sensitivity media for testing of cystic fibrosis isolates may give more useful results than conventional tests as in- vivo conditions are more closely simulated.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
A. O. Qamruddin, M. A. Alkawash, and J. S. Soothill
Antibiotic Susceptibility of Stenotrophomonas maltophilia in the Presence of Lactoferrin
Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4425 - 4426.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. T. Andres, M. Viejo-Diaz, F. Perez, and J. F. Fierro
Antibiotic Tolerance Induced by Lactoferrin in Clinical Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1613 - 1616.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
C. L. Munro and M. J. Grap
Oral Health and Care in the Intensive Care Unit: State of the Science
Am. J. Crit. Care., January 1, 2004; 13(1): 25 - 34.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. Alkawash, M. Head, I. Alshami, and J. S. Soothill
The effect of human lactoferrin on the MICs of doxycycline and rifampicin for Burkholderia cepacia and Pseudomonas aeruginosa strains
J. Antimicrob. Chemother., September 1, 1999; 44(3): 385 - 387.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.